Global Virtual Clinical Trials Market Report 2024

Virtual Clinical Trials Global Market Report 2023 – By Design (Observational Trials, Interventional Trials, Expanded Access Trials), By Phases (Phase I, Phase II, Phase III, Phase IV), By Indication (CNS, Autoimmuneor Inflammation, Cardiovascular Disease, Metabolicor Endocrinology, Infectious Disease, Oncology, Genitourinary, Ophthalmology, Other Indications) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $4000.00 | Pages : 200 | Published : January 2023 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Virtual Clinical Trials Market

Proud Members Of

checkslacipN checkaoirsN checkscipN

The virtual clinical trials refers to remote or decentralized clinical trials or studies that incorporate digital health technologies and enable remote participation outside the traditional brick-and-mortar clinical trial site using tablets, smartphone apps, or wearable sensors. Virtual clinical trials allow significant digital changes in clinical research methodology, resulting in a more patient-centric ecosystem.

The main design types of virtual clinical trials include observational trials, interventional trials, and expanded access trials. The observational trials refer to virtual clinical trials solutions and services used in the observational trials. Observational studies aim to learn what occurs to people in various contexts. The study team observes the participants but does not influence the therapies they get. The virtual clinical trials are used in Phase I, Phase II, Phase III, and Phase IV, and they are used in clinical trials of drugs are devices used in the treatment of CNS, autoimmune/inflammation, cardiovascular diseases, metabolic/endocrinology, infectious diseases, oncology, genitourinary, ophthalmology, and others.

The global virtual clinical trials market is segmented -

1) By Design: Observational Trials, Interventional Trials, Expanded Access Trials

2) By Phases: Phase I, Phase II, Phase III, Phase IV

3) By Indication: CNS, Autoimmune/Inflammation, Cardiovascular Disease, Metabolic/Endocrinology, Infectious Disease, Oncology, Genitourinary, Ophthalmology, Other Indications

The global virtual clinical trials market size will grow from $9.68 billion in 2022 to $10.49 billion in 2023 at a compound annual growth rate (CAGR) of 8.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global virtual clinical trials industry is expected to grow to $14.82 billion in 2027 at a CAGR of 9.0%.

The increasing investments by the government and pharmaceutical companies in the R&D for the development of new vaccines and drugs are driving the growth of the virtual clinical trials market. The R&D divisions in the medical industry are increasingly utilizing virtual clinical trial solutions and services to increase quality assurance and clinical data management of drugs and their products. For instance, according to the study published in Research!America, a non-profit medical and health research advisory, the medical and health R&D investment in the USA was recorded at $241.5 billion in 2020 an 11.1% increase from 2019. Additionally, in June 2021, an article published by Mckinsey, COVID-19 pandemic, has catalyzed the adoption of decentralized clinical trials by pharma companies while highlighting the critical benefits of virtual trials and improving the patient and physician experience. Therefore, the increasing investments by the government and pharmaceutical companies in new vaccines and drug development are driving the growth of virtual clinical trials.

Major players in the virtual clinical trials market are ICON, plc, Parexel International, IQVIA, Covance, PRA Health Sciences, LEO Innovation Lab, Medidata, Oracle Inc., CRF Health, Clinical Ink, Inc., Medable, Inc., Signant Health, Thread Research, Halo Health Systems, and Croprime.

Technology advancement is a key trend gaining popularity in the virtual clinical trials market. Major companies operating in the virtual clinical trials market are focused on providing technologically-advanced solutions to meet fast-growing industry demands and strengthen their market position. These companies are implementing new generation virtual clinical technologies into their services, such as wearable technologies, mHealth, blockchain, cloud computing, EMR integration, actionable data, threshold monitoring, AI, SFTP, ETL services, and others. For instance, In April 2022, Unlearn.AI, a US-based startup, will launch a new digital twin RCTs technology for clinical trials that enables smaller control groups while maintaining power and generating evidence suitable for supporting regulatory decisions using AI and historical data.

In December 2020, Signant Health, USA-based evidence generation company acquired VirTrial for an undisclosed amount. Through this acquisition, Signant Health would enhances its software stack to provide sponsors with superior evidence generation across traditional, decentralized, and hybrid trial models. VirTrial is a US-based company involved in offering telehealth platform for managing decentralized and virtual clinical trials.

North America was the largest region in the virtual clinical trials market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virtual clinical trials market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the virtual clinical trials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The virtual clinical trials market includes revenues earned by entities by providing services such as pilot studies and feasibility studies, prevention trials, screening trials, treatment trials, multi-arm multi-stage (mams) trials, cohort studies, case control studies, and cross sectional studies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The virtual clinical trials market research report is one of a series of new reports from The Business Research Company that provides virtual clinical trials market statistics, including virtual clinical trials industry global market size, regional shares, competitors with a virtual clinical trials market share, detailed virtual clinical trials market segments, market trends and opportunities, and any further data you may need to thrive in the virtual clinical trials industry. This virtual clinical trials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

    Table Of Contents

    1. Executive Summary

    2. Virtual Clinical Trials Market Characteristics

    3. Virtual Clinical Trials Market Trends And Strategies

    4. Virtual Clinical Trials – Macro Economic Scenario

    4.1 COVID-19 Impact On Virtual Clinical Trials Market

    4.2 Ukraine-Russia War Impact On Virtual Clinical Trials Market

    4.3 Impact Of High Inflation On Virtual Clinical Trials Market

    5. Virtual Clinical Trials Market Size And Growth

    5.1. Global Virtual Clinical Trials Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Virtual Clinical Trials Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Virtual Clinical Trials Market Segmentation

    6.1. Global Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Observational Trials

    Interventional Trials

    Expanded Access Trials

    6.2. Global Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Phase I

    Phase II

    Phase III

    Phase IV

    6.3. Global Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    CNS

    Autoimmune/Inflammation

    Cardiovascular Disease

    Metabolic/Endocrinology

    Infectious Disease

    Oncology

    Genitourinary

    Ophthalmology

    Other Indications

    7. Virtual Clinical Trials Market Regional And Country Analysis

    7.1. Global Virtual Clinical Trials Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Virtual Clinical Trials Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Virtual Clinical Trials Market

    8.1. Asia-Pacific Virtual Clinical Trials Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Virtual Clinical Trials Market

    9.1. China Virtual Clinical Trials Market Overview

    9.2. China Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Virtual Clinical Trials Market

    10.1. India Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Virtual Clinical Trials Market

    11.1. Japan Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Virtual Clinical Trials Market

    12.1. Australia Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Virtual Clinical Trials Market

    13.1. Indonesia Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Virtual Clinical Trials Market

    14.1. South Korea Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Virtual Clinical Trials Market

    15.1. Western Europe Virtual Clinical Trials Market Overview

    15.2. Western Europe Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Virtual Clinical Trials Market

    16.1. UK Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Virtual Clinical Trials Market

    17.1. Germany Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Virtual Clinical Trials Market

    18.4. France Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Virtual Clinical Trials Market

    19.1. Eastern Europe Virtual Clinical Trials Market Overview

    19.2. Eastern Europe Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Virtual Clinical Trials Market

    20.1. Russia Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Virtual Clinical Trials Market

    21.1. North America Virtual Clinical Trials Market Overview

    21.2. North America Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Virtual Clinical Trials Market

    22.1. USA Virtual Clinical Trials Market Overview

    22.2. USA Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Virtual Clinical Trials Market

    23.1. South America Virtual Clinical Trials Market Overview

    23.2. South America Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Virtual Clinical Trials Market

    24.1. Brazil Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Virtual Clinical Trials Market

    25.1. Middle East Virtual Clinical Trials Market Overview

    25.2. Middle East Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Virtual Clinical Trials Market

    26.1. Africa Virtual Clinical Trials Market Overview

    26.2. Africa Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Virtual Clinical Trials Market Competitive Landscape And Company Profiles

    27.1. Virtual Clinical Trials Market Competitive Landscape

    27.2. Virtual Clinical Trials Market Company Profiles

    27.2.1. ICON, plc

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Parexel International

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. IQVIA

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Covance

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. PRA Health Sciences

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Virtual Clinical Trials Market

    29. Virtual Clinical Trials Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Virtual Clinical Trials Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Virtual Clinical Trials Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: China, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: India, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: Japan, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Australia, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Indonesia, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: South Korea, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: Western Europe, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: UK, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Germany, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: France, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: Eastern Europe, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Russia, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: North America, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: USA, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: South America, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: Brazil, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Middle East, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Africa, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: ICON, plc Financial Performance
  • Table 47: Parexel International Financial Performance
  • Table 48: IQVIA Financial Performance
  • Table 49: Covance Financial Performance
  • Table 50: PRA Health Sciences Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Virtual Clinical Trials Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Virtual Clinical Trials Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: China, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: India, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: Japan, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Australia, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Indonesia, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: South Korea, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: Western Europe, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: UK, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Germany, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: France, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: Eastern Europe, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Russia, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: North America, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: USA, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: South America, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: Brazil, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Middle East, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Africa, Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: ICON, plc Financial Performance
  • Figure 47: Parexel International Financial Performance
  • Figure 48: IQVIA Financial Performance
  • Figure 49: Covance Financial Performance
  • Figure 50: PRA Health Sciences Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report